Technology | Artificial Intelligence | May 15, 2019

FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism

Artificial intelligence solution flags and triages PE cases in chest CT scans

FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism

May 15, 2019 — Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA) clearance for an additional product in its expanding suite of AI-based workflow orchestration solutions. The clearance is for Aidoc's Pulmonary Embolism (PE) solution that works with radiologists to flag and triage PE cases in chest computed tomography (CT) scans. The approval comes just weeks after Aidoc closed a $27 million funding round, bringing its total funding to $40 million.

"In addition to the significant value provided to the department by Aidoc's ICH [Intracranial Hemorrhage] solution, we recently added the PE module to the workflow," said Barry Pressman, M.D., chair of imaging at Cedars-Sinai Medical Center. "I was impressed by the fact that the coverage continuously grows, allowing us to add this product in the workflow of more radiologists, becoming part of our daily work. I was also pleased by the ability of the software to prioritize PE studies accurately."

In the United States alone, up to 200,000 people a year die due to PE.1 Undetected or late-detected PE is one of the most common causes of preventable death in hospitalized patients. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making AI-driven workflow triage especially beneficial. Recent research published at the 2019 European Congress of Radiology (ECR) in Vienna2 further shows the accuracy and value Aidoc's solution can provide, according to the company.

"It is clear that AI will play a tremendous role in the future of radiology," said Daniel J. Durand, M.D., chair of radiology at LifeBridge Health, Baltimore. "Considering the complexity of vascular diagnosis, we are eager to see how Aidoc's solutions can benefit our pulmonary embolism patients and bring tomorrow's technology to LifeBridge Health today."

Aidoc's solutions analyze medical images directly after the patient is scanned and notify the radiologists of cases with suspected findings, to assist with prioritization of time-sensitive and potentially life-threatening cases. Aidoc cuts the time from scan to diagnosis for some patients from hours to under five minutes, speeding up treatment and improving prognosis.

For more information: www.aidoc.com

References

1. Tarbox A.K., Swaroop M. Pulmonary embolism. International Journal of Critical Illness & Injury Science, published online March 22, 2013. DOI: 10.4103/2229-5151.109427

2. Weikert T.J., Winkel D.J., Bremerich J., et al. Abstract B-1211: AI-powered detection of pulmonary embolism in CT pulmonary angiograms: a validation study of the diagnostic performance of prototype algorithms. Presented at ECR 2019, March 2, 2019.

Related Content

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019. Photo by Greg Freiherr

Feature | Radiology Business | July 22, 2019 | By Greg Freiherr
Efforts to reform healthcare are booming, b
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...